MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo

Nasopharyngeal carcinoma (NPC) is an endemic tumor with a relatively high incidence in Southern China and Southeast Asia. Paclitaxel combination chemotherapy has been used for treatment of advanced NPC. However, treatment failure often occurs due to development of acquired paclitaxel resistance. In...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Biol Ther
Hauptverfasser: Peng, Xiaowei, Cao, Peiguo, Li, Jingjing, He, Dong, Han, Shuang, Zhou, Jianda, Tan, Guolin, Li, Wei, Yu, Fenghui, Yu, Jianjun, Li, Zan, Cao, Ke
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2015
Schlagworte:
Research Papers
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622873/
https://ncbi.nlm.nih.gov/pubmed/25756509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2014.1001287
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge